ArriVent BioPharma, Inc.
(NASDAQ: AVBP)
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
22.250 -
+0.630
(+2.91%)
价格区间
21.710 - 23.400
(7.78%)
开盘
22.030
昨收
21.620
买
22.230
买盘
113
卖
22.370
卖盘
4
成交量
215,737
成交额
4,084,099
注释
-
数据延迟。最后一次更新13 Feb 2026 00:05.
数据提供商
查看所有活动
Loading Chart...
Please login to view stock data and analysis
